Skip to content
Study details
Enrolling now

Vagus Nerve Stimulation (VNS) as a Treatment for Fibromyalgia Patients

Massachusetts General Hospital
NCT IDNCT06009159ClinicalTrials.gov data as of Apr 2026
Target enrollment

60

Study length

about 2.3 years

Ages

18–80

Locations

1 site in MA

What this study is about

Researchers are testing whether vagus nerve stimulation can improve pain and related symptoms in people with fibromyalgia. The treatment involves using a device to stimulate the vagus nerve. The trial will last approximately 852 days.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Transcutaneous Vagus Nerve Stimulation

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: A modified McGill Pain Questionnaire

Secondary: Blood inflammation marker, Medical Outcomes Study Questionnaire Short Form 36, Medical Outcomes Study Sleep Scale, Multidimensional Fatigue Inventory

Devices

therapeutic

Body systems

Musculoskeletal